Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Shopping Cart 0
countryflagAU
Login

Ebos Group Ltd

Healthcare AU EBO

18.72AUD
-0.32(1.68%)

Last update at 2026-03-11T05:39:00Z

Day Range

18.6619.11
LowHigh

52 Week Range

19.0436.77
LowHigh

Fundamentals

  • Previous Close 19.04
  • Market Cap3995.85M
  • Volume128868
  • P/E Ratio18.43
  • Dividend Yield5.36%
  • EBITDA497.71M
  • Revenue TTM13043.20M
  • Revenue Per Share TTM64.85
  • Gross Profit TTM 1705.98M
  • Diluted EPS TTM1.05

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax 325.45M 418.60M 406.39M 327.37M 282.60M
Minority interest -0.67514M -1.67832M -10.96093M 0.63M -5.32100M
Net income 231.66M 296.71M 275.74M 224.64M 199.09M
Selling general administrative 632.72M 619.43M 578.28M 467.06M 382.43M
Selling and marketing expenses - 117.61M - - -
Gross profit 1762.86M 1784.21M 1698.92M 1380.71M 1066.34M
Reconciled depreciation 158.18M 140.81M 135.80M 90.78M 78.05M
Ebit 421.73M 509.61M 495.06M 365.49M 313.51M
Ebitda 579.91M 650.42M 630.86M 456.27M 391.57M
Depreciation and amortization 158.18M 140.81M 135.80M 90.78M 78.05M
Non operating income net other - - - - -
Operating income 455.58M 527.24M 483.20M 382.22M 308.56M
Other operating expenses 12753.10M 13883.87M 10402.47M 9496.65M 8072.80M
Interest expense 96.28M 109.11M 73.79M 25.44M 22.18M
Tax provision 93.12M 120.21M 119.69M 103.35M 84.85M
Interest income 7.64M 8.00M 9.30M 3.06M 0.77M
Net interest income -114.61936M -102.29567M -76.78855M -31.80508M -21.41184M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 93.12M 120.21M 119.69M 103.35M 84.85M
Total revenue 13208.68M 14411.12M 13317.45M 11901.67M 9888.13M
Total operating expenses 1307.28M 1256.96M 1199.92M 985.25M 748.81M
Cost of revenue 11445.81M 12626.91M 11618.53M 10520.96M 8821.80M
Total other income expense net -130.13460M -108.64400M -15.81891M -36.28673M -5.23155M
Discontinued operations - - - - -
Net income from continuing ops 232.33M 298.39M 286.70M 224.01M 197.75M
Net income applicable to common shares - - 253.37M 202.60M 185.30M
Preferred stock and other adjustments - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 7837.02M 7368.95M 7005.15M 6945.94M 4243.86M
Intangible assets 608.00M 579.01M 560.74M 267.56M 174.54M
Earning assets - - - - -
Other current assets 46.10M 65.89M 68.81M 58.27M 15.51M
Total liab 4904.08M 4726.36M 4498.50M 4560.36M 2733.49M
Total stockholder equity 2949.89M 2678.11M 2649.25M 2511.16M 1516.09M
Deferred long term liab - - - - -
Other current liab 383.20M 337.63M 620.43M 827.05M 438.54M
Common stock 2433.05M 2116.71M 2056.66M 2007.50M 1067.60M
Capital stock 2433.05M 2116.71M 2056.66M 2007.50M 1067.60M
Retained earnings 540.60M 574.13M 608.80M 534.06M 465.73M
Other liab - - 284.94M 327.90M 138.89M
Good will 2417.34M 2259.28M 2150.80M 2372.81M 1073.75M
Other assets - - 208.60M 182.16M 141.84M
Cash 198.40M 236.98M 230.59M 573.58M 181.53M
Cash and equivalents - - - - -
Total current liabilities 2815.68M 3413.89M 2892.65M 2784.82M 2017.81M
Current deferred revenue - - -98.61549M -416.90041M -163.86633M
Net debt 1547.97M 1558.22M 1165.59M 1253.23M 549.45M
Short term debt 87.91M 899.20M 100.41M 414.84M 164.54M
Short long term debt 17.00M 836.66M 45.84M 367.58M 125.33M
Short long term debt total 1746.37M 1795.20M 1396.17M 1826.82M 730.98M
Other stockholder equity - 0.00000M -2657.77601M -2534.04824M -1530.97452M
Property plant equipment - - 660.67M 576.98M 464.94M
Total current assets 3322.99M 3258.51M 3272.26M 3398.00M 2282.85M
Long term investments 71.51M 61.67M 58.39M 65.86M 60.77M
Net tangible assets - - -57.24000M -116.53900M 249.24M
Short term investments - - 14.73M 17.02M -0.09330M
Net receivables 1629.99M 1633.05M 1629.69M 1524.26M 1242.61M
Long term debt 1170.15M 513.66M 1018.99M 1160.06M 347.66M
Inventory 1448.51M 1322.60M 1343.17M 1241.88M 843.19M
Accounts payable 2344.57M 2177.06M 2270.42M 1959.83M 1578.60M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -23.76763M -12.72399M -16.21395M -30.39805M -17.23971M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 36.96M 37.67M 19.17M 1.51M 0.03M
Deferred long term asset charges - - - - -
Non current assets total 4514.04M 4110.43M 3732.89M 3547.94M 1961.01M
Capital lease obligations 559.22M 444.88M 331.34M 299.18M 258.00M
Long term debt total - - - - 527.19M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments -397.16808M -413.15778M -167.88007M -7.89600M -0.49700M
Change to liabilities - - 270.73M 414.97M 209.62M
Total cashflows from investing activities -397.16808M -408.74250M -154.26500M -1396.19700M -113.76300M
Net borrowings -151.84559M 281.35M -450.61700M 864.52M -167.12000M
Total cash from financing activities -91.41380M 37.51M -595.41952M 1664.95M -279.33383M
Change to operating activities - - 20.56M 117.91M 9.94M
Net income 231.66M 297.34M 274.94M 223.98M 198.79M
Change in cash -35.13729M 5.46M -332.38655M 386.25M -81.47094M
Begin period cash flow 233.53M 231.52M 562.97M 187.33M 263.00M
End period cash flow 198.40M 236.98M 230.59M 573.58M 181.53M
Total cash from operating activities 450.63M 381.31M 424.69M 274.98M 320.03M
Issuance of capital stock 268.96M 1.76M 86.21M 877.27M 34.52M
Depreciation - 141.11M 135.41M 90.51M 77.93M
Other cashflows from investing activities -125.11898M -57.71431M - - -31.50300M
Dividends paid -147.56434M -170.59441M -191.23953M -170.87260M -134.29247M
Change to inventory - 26.06M -141.34997M -352.88971M -50.48860M
Change to account receivables - 3.24M -133.93751M -240.55145M -143.66219M
Sale purchase of stock - - 26.05M 1287.16M 53.29M
Other cashflows from financing activities -60.95940M -75.00983M -53.30613M -45.39417M -37.88654M
Change to netincome - - 15.58M -20.04200M -18.20500M
Capital expenditures 54.25M 92.33M 107.03M 99.38M 88.39M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital - -64.06647M -275.28749M -593.44116M -194.15079M
Stock based compensation - 12.91M 9.78M 6.93M 4.02M
Other non cash items 450.63M 445.38M 14.34M -39.51152M 43.31M
Free cash flow 396.38M 288.18M 317.66M 175.59M 231.65M

Peer Comparison

Sector: Healthcare Industry: Medical Distribution

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
EBO
Ebos Group Ltd		 -0.32 1.68% 18.72 18.43 17.01 0.31 1.51 0.47 10.81
SIG
Sigma Healthcare Ltd		 -0.03 1.09% 2.72 56.00 38.17 3.39 6.43 5.56 40.06
PGC
Paragon Care Ltd		 -0.005 2.70% 0.18 - 5.98 0.09 0.98 0.18 17.79
MYX
Mayne Pharma Group Ltd		 0.18 7.29% 2.65 - 263.16 0.49 0.55 0.42 5.70
CYC
Cyclopharm Ltd		 0.04 5.48% 0.77 - 116.28 2.78 3.29 5.41 -24.5712

Reports Covered

Stock Research & News

View All

Profile

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services. It also offers community based health care services and programs; vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; Pharmacy Choice, a five step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that helps members drive their retail businesses. Further, it offers healthcare distribution, warehousing, clinical trial management, and product registration services; clinical trial logistics; aesthetic healthcare devices, medical-grade cosmeceuticals, and injectables; and surgical devices and medical consumables. Additionally, the company provides pet nutrition, treats, clean-up, and grooming products and accessories; and wholesales veterinary products. The company was formerly known as Early Bros Dental & Surgical Supplies Ltd. and changed its name to EBOS Group Limited in 1986. EBOS Group Limited was incorporated in 1922 and is headquartered in Docklands, Australia.

Ebos Group Ltd

737 Bourke Street, Docklands, VIC, Australia, 3008

Key Executives

Name Title Year Born
Mr. John Cullity Chief Exec. Officer NA
Mr. Leonard Hansen CFO & Chief Accountant NA
Ms. Andrea Bell Chief Information Officer NA
Martin Krauskopf Exec. GM of Strategy, Mergers & Acquisitions and GM of Investor Relations NA
Ms. Janelle Cain Gen. Counsel NA
Ms. Jacinta McCarthy Group Gen. Mang. of HR NA
Mr. Simon Bunde Exec. Gen. Mang. of Strategic Operations, ESG & Innovation NA
Ms. Julie Dillon Chief Exec. Officer of Animal Care NA
Mr. Matthew Muscio Chief Exec. Officer of Medical Technology NA
Mr. Brett Barons Chief Exec. Officer of Symbion NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.